In this paper recently published in Epilepsia, Aledo-Serrano et al. evaluated the impact of the pandemic on patients with genetic, developmental and epileptic encephalopathies (DEEs) and their caregivers in Spain.

In this retrospective, multicentre study, the author systematically characterised neurological symptoms and neuroimaging features in hospitalised COVID-19 patients from multiple institutions in Italy.

In this systematic review and meta-analysis, the authors analysed studies or preprints reporting data on the psychiatric and neuropsychiatric presentations of individuals with suspected or laboratory-confirmed coronavirus infection (SARS coronavirus, MERS coronavirus, or SARS coronavirus 2).

In this retrospective, single centre cohort study, recently published in Neurology, Benussi et al., reported clinical and laboratory characteristics, as well as treatment and clinical outcomes of patients admitted for neurological diseases with and without COVID-19.

In this paper just published in the European Journal of Neurology, the European Society of Neurosonology and Cerebral Hemodynamics (ESNCH) provided recommendations for the performance of neurovascular ultrasound investigations, with the aim of protecting both patients and ultrasound providers.

In this paper, the authors report a series of young COVID-19 patients presenting with cerebral venous system thrombosis.

In this paper, the authors report 2 cases of patients presenting with cerebral venous thrombosis (CVT) associated with COVID-19 infection.

In this paper, recently published in the American Journal of Neuroradiology, Franceschi et al. present 2 patients with COVID-19 infection who demonstrated imaging findings compatible with haemorrhagic posterior reversible encephalopathy syndrome (PRES).

In this paper, the authors describe a case of facial nerve palsy as a neurological manifestation of Covid-19 Infection.

In this nice paper, recently published in the European Journal of Neurology, the authors reviewed neurological manifestations in patients with COVID-19 and the possible neuro-invasive mechanisms of Sars-CoV-2.

In this paper, the authors report three patients infected with SARS-CoV-2 who developed generalised myoclonus. Two men and one woman (aged 63 to 88) presented with mild hypersomnia and generalised myoclonus following onset of the so-called “inflammatory” phase of COVID-19 infection.

In this article, just published in Lancet, the authors report an analysis of multinational registry data on the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19.

In this article, just published in the New England Journal of Medicine, Beigel et al. conducted a double-blind, randomised, placebo-controlled trial of intravenous remdesivir in adults hospitalised with Covid-19 with evidence of lower respiratory tract involvement.

Is ambulatory (at home) polysomnography valid and reliable on a scientific basis?

It is with great pride and gratitude that we thank everyone who took part in the 6th Annual Congress of the European Academy of Neurology last week. This was the first ever EAN Virtual Congress and truly a pioneering event in terms of neurology and academic conferences more widely.